Symbiotix Biotherapies awarded NIAID grant to develop microbiome-derived therapeutics June 8, 2015 No Comments
Medifocus obtains option to license cancer immunotherapy technology from Duke University June 2, 2015 No Comments
Juno and Editas collaborate on next-generation CAR T and TCR therapies for cancer May 29, 2015 No Comments
RSS